Does Keytruda Have Official Copay Assistance?
Merck, the maker of Keytruda (pembrolizumab), runs the Keytruda Savings Program. It covers copays, coinsurance, and deductibles for eligible commercially insured patients. Savings can reach $25,000 per year, reducing out-of-pocket costs to as low as $0 per infusion. Patients must have private insurance, not be on government programs like Medicare/Medicaid, and meet income limits in some cases. Enrollment is online or by phone at 1-855-4KEYTRUDA.[1]
Who Qualifies and How to Apply?
Eligibility requires U.S. residency, a valid Keytruda prescription, and commercial coverage that covers the drug. Excludes those on government insurance or free trial offers. Apply via the official site (keytruda.com/savings), doctor’s office, or app. Approval is instant for many; cards activate at pharmacies or infusion centers. Cards expire after 12 months or if coverage changes.[1]
What About Medicare Patients?
Medicare patients can't use the Keytruda Savings Program due to federal anti-kickback rules. Instead, options include Merck's Patient Assistance Program for low-income uninsured/underinsured (income up to 500% of federal poverty level), providing free Keytruda. Apply through Merck's portal or nonprofits like PAN Foundation, which has a Keytruda-specific fund with grants up to $10,000+ annually.[2][3]
Are There Third-Party Copay Cards or Foundations?
- RxAssist and NeedyMeds: List Keytruda assistance, linking to Merck programs and state-specific aid.
- Patient Access Network (PAN): Covers copays for cancer patients with income 400-500% FPL; apply online.
- CancerCare and Leukemia & Lymphoma Society: Offer grants for copays/transport, not drug-specific limits.
- GoodRx or SingleCare: Discount cards cut cash prices (Keytruda averages $12,500+/dose without aid), but less effective for insured patients.[4][5]
Compare options:
| Program | Best For | Max Assistance | Exclusions |
|---------|----------|----------------|------------|
| Keytruda Savings | Commercial insurance | $25K/year | Medicare, uninsured |
| PAN Foundation | Underinsured cancer patients | Varies (~$10K) | High income |
| Merck PAP | Uninsured low-income | Free drug | Commercial insurance |
How Much Does Keytruda Cost Without Assistance?
List price is about $11,000-$12,500 per infusion (every 3-6 weeks), totaling $200,000+ yearly. Insurance copays without aid can hit 20-30% ($40K+). Assistance drops this sharply for eligibles.[6]
Watch for Changes Due to Patents and Biosimilars
Keytruda's main patents expire around 2028, with some pediatric extensions to 2031-2035. Challenges from Amgen, Samsung Bioepis, and others could accelerate generics/biosimilars, potentially lowering costs. No biosimilars approved yet; Merck defends patents aggressively.7
[1]: keytruda.com/savings
[2]: merckhelps.com
[3]: panfoundation.org
[4]: rxassist.org
[5]: needymeds.org
[6]: goodrx.com/keytruda